COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment
Keyword(s):
2004 ◽
Vol 90
(2)
◽
pp. 423-429
◽
Keyword(s):
2015 ◽
Vol 63
(6)
◽
pp. 408-416
◽
Keyword(s):
Keyword(s):
Keyword(s):
2009 ◽
Vol 106
(9)
◽
pp. 3372-3377
◽
Keyword(s):
2005 ◽
Vol 3
(1)
◽
pp. 16-17
Keyword(s):
Keyword(s):
2010 ◽
Vol 16
(5)
◽
pp. 1605-1612
◽